Factor VIIa binding and internalization in hepatocytes

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Factor VIIa binding and internalization in hepatocytes. / Hjortoe, G; Sorensen, B B; Petersen, L C; Rao, L.V.M.

I: Journal of Thrombosis and Haemostasis, Bind 3, Nr. 10, 10.2005, s. 2264-73.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Hjortoe, G, Sorensen, BB, Petersen, LC & Rao, LVM 2005, 'Factor VIIa binding and internalization in hepatocytes', Journal of Thrombosis and Haemostasis, bind 3, nr. 10, s. 2264-73. https://doi.org/10.1111/j.1538-7836.2005.01542.x

APA

Hjortoe, G., Sorensen, B. B., Petersen, L. C., & Rao, L. V. M. (2005). Factor VIIa binding and internalization in hepatocytes. Journal of Thrombosis and Haemostasis, 3(10), 2264-73. https://doi.org/10.1111/j.1538-7836.2005.01542.x

Vancouver

Hjortoe G, Sorensen BB, Petersen LC, Rao LVM. Factor VIIa binding and internalization in hepatocytes. Journal of Thrombosis and Haemostasis. 2005 okt.;3(10):2264-73. https://doi.org/10.1111/j.1538-7836.2005.01542.x

Author

Hjortoe, G ; Sorensen, B B ; Petersen, L C ; Rao, L.V.M. / Factor VIIa binding and internalization in hepatocytes. I: Journal of Thrombosis and Haemostasis. 2005 ; Bind 3, Nr. 10. s. 2264-73.

Bibtex

@article{8e0c0868cf45494a98d0705738708699,
title = "Factor VIIa binding and internalization in hepatocytes",
abstract = "The liver is believed to be the primary clearance organ for coagulation proteases, including factor VIIa (FVIIa). However, at present, clearance mechanisms for FVIIa in liver are unknown. To obtain information on the FVIIa clearance mechanism, we investigated the binding and internalization of FVIIa in liver cells using a human hepatoma cell line (HEPG2), and primary rat and human hepatocytes as cell models. 125I-FVIIa bound to HEPG2 cells in a time- and dose-dependent manner. Anti-tissue factor antibodies reduced the binding by about 25%, whereas 50-fold molar excess of unlabeled FVIIa had no effect. HEPG2 cells internalized FVIIa with a rate of 10 fmol 10(-5) cells h(-1). In contrast to HEPG2 cells, FVIIa binding to primary rat hepatocytes was completely independent of TF, and excess unlabeled FVIIa partly reduced the binding of 125I-FVIIa to rat hepatocytes. Further, compared with HEPG2 cells, three- to fourfold more FVIIa bound to rat primary hepatocytes, and the bound FVIIa was internalized at a faster rate. Similar FVIIa binding and internalization profiles were observed in primary human hepatocytes. Plasma inhibitors had no effect on FVIIa binding and internalization in hepatocytes. In contrast, annexin V, which binds to phosphatidylserine, blocked the binding and internalization. Consistent with this, binding of gla-domain-deleted FVIIa to hepatocytes was markedly diminished. In summary, the data presented herein reveal differences between HEPG2 cells and primary liver cells in FVIIa binding and internalization, and suggest that the rapid turnover of membrane and not a receptor-mediated endocytosis may be responsible for internalization of FVII/FVIIa in primary hepatocytes.",
keywords = "Animals, Annexin A5, Cell Line, Cell Membrane, Cells, Cultured, Factor VIIa, Hepatocytes, Humans, Phosphatidylserines, Protein Binding, Protein Transport, Rats, Thromboplastin, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.",
author = "G Hjortoe and Sorensen, {B B} and Petersen, {L C} and L.V.M. Rao",
year = "2005",
month = oct,
doi = "10.1111/j.1538-7836.2005.01542.x",
language = "English",
volume = "3",
pages = "2264--73",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "10",

}

RIS

TY - JOUR

T1 - Factor VIIa binding and internalization in hepatocytes

AU - Hjortoe, G

AU - Sorensen, B B

AU - Petersen, L C

AU - Rao, L.V.M.

PY - 2005/10

Y1 - 2005/10

N2 - The liver is believed to be the primary clearance organ for coagulation proteases, including factor VIIa (FVIIa). However, at present, clearance mechanisms for FVIIa in liver are unknown. To obtain information on the FVIIa clearance mechanism, we investigated the binding and internalization of FVIIa in liver cells using a human hepatoma cell line (HEPG2), and primary rat and human hepatocytes as cell models. 125I-FVIIa bound to HEPG2 cells in a time- and dose-dependent manner. Anti-tissue factor antibodies reduced the binding by about 25%, whereas 50-fold molar excess of unlabeled FVIIa had no effect. HEPG2 cells internalized FVIIa with a rate of 10 fmol 10(-5) cells h(-1). In contrast to HEPG2 cells, FVIIa binding to primary rat hepatocytes was completely independent of TF, and excess unlabeled FVIIa partly reduced the binding of 125I-FVIIa to rat hepatocytes. Further, compared with HEPG2 cells, three- to fourfold more FVIIa bound to rat primary hepatocytes, and the bound FVIIa was internalized at a faster rate. Similar FVIIa binding and internalization profiles were observed in primary human hepatocytes. Plasma inhibitors had no effect on FVIIa binding and internalization in hepatocytes. In contrast, annexin V, which binds to phosphatidylserine, blocked the binding and internalization. Consistent with this, binding of gla-domain-deleted FVIIa to hepatocytes was markedly diminished. In summary, the data presented herein reveal differences between HEPG2 cells and primary liver cells in FVIIa binding and internalization, and suggest that the rapid turnover of membrane and not a receptor-mediated endocytosis may be responsible for internalization of FVII/FVIIa in primary hepatocytes.

AB - The liver is believed to be the primary clearance organ for coagulation proteases, including factor VIIa (FVIIa). However, at present, clearance mechanisms for FVIIa in liver are unknown. To obtain information on the FVIIa clearance mechanism, we investigated the binding and internalization of FVIIa in liver cells using a human hepatoma cell line (HEPG2), and primary rat and human hepatocytes as cell models. 125I-FVIIa bound to HEPG2 cells in a time- and dose-dependent manner. Anti-tissue factor antibodies reduced the binding by about 25%, whereas 50-fold molar excess of unlabeled FVIIa had no effect. HEPG2 cells internalized FVIIa with a rate of 10 fmol 10(-5) cells h(-1). In contrast to HEPG2 cells, FVIIa binding to primary rat hepatocytes was completely independent of TF, and excess unlabeled FVIIa partly reduced the binding of 125I-FVIIa to rat hepatocytes. Further, compared with HEPG2 cells, three- to fourfold more FVIIa bound to rat primary hepatocytes, and the bound FVIIa was internalized at a faster rate. Similar FVIIa binding and internalization profiles were observed in primary human hepatocytes. Plasma inhibitors had no effect on FVIIa binding and internalization in hepatocytes. In contrast, annexin V, which binds to phosphatidylserine, blocked the binding and internalization. Consistent with this, binding of gla-domain-deleted FVIIa to hepatocytes was markedly diminished. In summary, the data presented herein reveal differences between HEPG2 cells and primary liver cells in FVIIa binding and internalization, and suggest that the rapid turnover of membrane and not a receptor-mediated endocytosis may be responsible for internalization of FVII/FVIIa in primary hepatocytes.

KW - Animals

KW - Annexin A5

KW - Cell Line

KW - Cell Membrane

KW - Cells, Cultured

KW - Factor VIIa

KW - Hepatocytes

KW - Humans

KW - Phosphatidylserines

KW - Protein Binding

KW - Protein Transport

KW - Rats

KW - Thromboplastin

KW - Journal Article

KW - Research Support, N.I.H., Extramural

KW - Research Support, U.S. Gov't, P.H.S.

U2 - 10.1111/j.1538-7836.2005.01542.x

DO - 10.1111/j.1538-7836.2005.01542.x

M3 - Journal article

C2 - 16194204

VL - 3

SP - 2264

EP - 2273

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 10

ER -

ID: 182199422